TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature
Clinical trial NCT02641847 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02641847
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2023-12-01
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.